Management of Hyperlipidaemia using KNEA: A case report

Elevated lipid levels in the blood, often termed Hyperlipidaemia, significantly raise the risk of developing atherosclerotic cardiovascular disease (ASCVD). Dyslipidemia is widely recognized as a key factor in the development of cardiovascular diseases and stroke. The present case report shows a patient with hyperlipidemia who was successfully treated with Siddha therapeutic regimens KNEA (<i>Keelanelli Maathirai</i>, <i>Nerunjil Kudineer</i>, <i>Eladhi Chooranam Maathirai</i>, <i>Ayabirungaraja Karpam</i>). The therapeutic medications have its own Antihyperlipidemic, hepatoprotective, antioxidant and nephroprotective properties. In this case report, total cholesterol (TC) was reduced by 178 mg/dL, dropping from 205 mg/dL, while low-density lipoprotein cholesterol (LDL-C) decreased by 108 mg/dL, going down from 127 mg/dL. Additionally, the HDL-C level increased from 33 mg/dL to 42 mg/dL. Thus, the use of KNEA in the management of Hyperlipidaemia through Siddha medications is shown.